BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) today reported financial and operating results for the third quarter of 2007. The company had a net loss in the quarter of $4.2 million or $0.21 per share. At the end of the third quarter of 2007, the company had $68.5 million in cash, cash equivalents and marketable securities.
